Discovering anticancer drug target combinations via network-informed signaling-based approach Article Swipe
Bengi Ruken Yavuz
,
Hyunbum Jang
,
Ruth Nussinov
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s43856-025-01150-9
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s43856-025-01150-9
Our network-based approach discovers optimal protein co-target combinations to counter resistance, selecting co-targets from alternative pathways and their connectors.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s43856-025-01150-9
- https://www.nature.com/articles/s43856-025-01150-9.pdf
- OA Status
- gold
- References
- 98
- OpenAlex ID
- https://openalex.org/W4415294870
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415294870Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s43856-025-01150-9Digital Object Identifier
- Title
-
Discovering anticancer drug target combinations via network-informed signaling-based approachWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-17Full publication date if available
- Authors
-
Bengi Ruken Yavuz, Hyunbum Jang, Ruth NussinovList of authors in order
- Landing page
-
https://doi.org/10.1038/s43856-025-01150-9Publisher landing page
- PDF URL
-
https://www.nature.com/articles/s43856-025-01150-9.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.nature.com/articles/s43856-025-01150-9.pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
98Number of works referenced by this work
Full payload
| id | https://openalex.org/W4415294870 |
|---|---|
| doi | https://doi.org/10.1038/s43856-025-01150-9 |
| ids.doi | https://doi.org/10.1038/s43856-025-01150-9 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41107466 |
| ids.openalex | https://openalex.org/W4415294870 |
| fwci | 0.0 |
| type | article |
| title | Discovering anticancer drug target combinations via network-informed signaling-based approach |
| biblio.issue | 1 |
| biblio.volume | 5 |
| biblio.last_page | 428 |
| biblio.first_page | 428 |
| topics[0].id | https://openalex.org/T10887 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Bioinformatics and Genomic Networks |
| topics[1].id | https://openalex.org/T10211 |
| topics[1].field.id | https://openalex.org/fields/17 |
| topics[1].field.display_name | Computer Science |
| topics[1].score | 0.9994000196456909 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1703 |
| topics[1].subfield.display_name | Computational Theory and Mathematics |
| topics[1].display_name | Computational Drug Discovery Methods |
| topics[2].id | https://openalex.org/T10621 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9769999980926514 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Gene Regulatory Network Analysis |
| is_xpac | False |
| apc_list.value | 2290 |
| apc_list.currency | GBP |
| apc_list.value_usd | 2808 |
| apc_paid.value | 2290 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 2808 |
| language | en |
| locations[0].id | doi:10.1038/s43856-025-01150-9 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210167893 |
| locations[0].source.issn | 2730-664X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2730-664X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Communications Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310319908 |
| locations[0].source.host_organization_name | Nature Portfolio |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://www.nature.com/articles/s43856-025-01150-9.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Communications Medicine |
| locations[0].landing_page_url | https://doi.org/10.1038/s43856-025-01150-9 |
| locations[1].id | pmid:41107466 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Communications medicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41107466 |
| locations[2].id | pmh:oai:doaj.org/article:379c73bd36df4b86a1503c562f01c20e |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Communications Medicine, Vol 5, Iss 1, Pp 1-17 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/379c73bd36df4b86a1503c562f01c20e |
| locations[3].id | pmh:oai:europepmc.org:11342357 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12534536 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5002972643 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3472-8767 |
| authorships[0].author.display_name | Bengi Ruken Yavuz |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210130649, https://openalex.org/I4210140884 |
| authorships[0].affiliations[0].raw_affiliation_string | Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD, USA |
| authorships[0].institutions[0].id | https://openalex.org/I4210130649 |
| authorships[0].institutions[0].ror | https://ror.org/03v6m3209 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210130649, https://openalex.org/I4210140884 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Frederick National Laboratory for Cancer Research |
| authorships[0].institutions[1].id | https://openalex.org/I4210140884 |
| authorships[0].institutions[1].ror | https://ror.org/040gcmg81 |
| authorships[0].institutions[1].type | government |
| authorships[0].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210140884 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | National Cancer Institute |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Bengi Ruken Yavuz |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD, USA |
| authorships[1].author.id | https://openalex.org/A5071084031 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9402-4051 |
| authorships[1].author.display_name | Hyunbum Jang |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210130649, https://openalex.org/I4210140884 |
| authorships[1].affiliations[0].raw_affiliation_string | Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210130649 |
| authorships[1].institutions[0].ror | https://ror.org/03v6m3209 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210130649, https://openalex.org/I4210140884 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Frederick National Laboratory for Cancer Research |
| authorships[1].institutions[1].id | https://openalex.org/I4210140884 |
| authorships[1].institutions[1].ror | https://ror.org/040gcmg81 |
| authorships[1].institutions[1].type | government |
| authorships[1].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210140884 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | National Cancer Institute |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Hyunbum Jang |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD, USA |
| authorships[2].author.id | https://openalex.org/A5025357844 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-8115-6415 |
| authorships[2].author.display_name | Ruth Nussinov |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210140884 |
| authorships[2].affiliations[0].raw_affiliation_string | Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD, USA |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I4210130649 |
| authorships[2].affiliations[1].raw_affiliation_string | Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD, USA |
| authorships[2].institutions[0].id | https://openalex.org/I4210130649 |
| authorships[2].institutions[0].ror | https://ror.org/03v6m3209 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210130649, https://openalex.org/I4210140884 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Frederick National Laboratory for Cancer Research |
| authorships[2].institutions[1].id | https://openalex.org/I4210140884 |
| authorships[2].institutions[1].ror | https://ror.org/040gcmg81 |
| authorships[2].institutions[1].type | government |
| authorships[2].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210140884 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | National Cancer Institute |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | Ruth Nussinov |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD, USA, Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD, USA |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.nature.com/articles/s43856-025-01150-9.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-18T00:00:00 |
| display_name | Discovering anticancer drug target combinations via network-informed signaling-based approach |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10887 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Bioinformatics and Genomic Networks |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1038/s43856-025-01150-9 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210167893 |
| best_oa_location.source.issn | 2730-664X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2730-664X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Communications Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310319908 |
| best_oa_location.source.host_organization_name | Nature Portfolio |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://www.nature.com/articles/s43856-025-01150-9.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Communications Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s43856-025-01150-9 |
| primary_location.id | doi:10.1038/s43856-025-01150-9 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210167893 |
| primary_location.source.issn | 2730-664X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2730-664X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Communications Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310319908 |
| primary_location.source.host_organization_name | Nature Portfolio |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://www.nature.com/articles/s43856-025-01150-9.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Communications Medicine |
| primary_location.landing_page_url | https://doi.org/10.1038/s43856-025-01150-9 |
| publication_date | 2025-10-17 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4226055977, https://openalex.org/W4311247426, https://openalex.org/W4398224376, https://openalex.org/W4212966936, https://openalex.org/W2912993305, https://openalex.org/W4318166181, https://openalex.org/W4220776360, https://openalex.org/W3041722687, https://openalex.org/W4390747020, https://openalex.org/W4385986528, https://openalex.org/W2129242642, https://openalex.org/W3109453522, https://openalex.org/W3157276232, https://openalex.org/W3170960533, https://openalex.org/W2999142839, https://openalex.org/W3131053290, https://openalex.org/W4313703146, https://openalex.org/W4302287384, https://openalex.org/W4230568286, https://openalex.org/W4317036722, https://openalex.org/W4392561554, https://openalex.org/W4404578455, https://openalex.org/W3006386963, https://openalex.org/W2939519112, https://openalex.org/W4390911994, https://openalex.org/W2608863179, https://openalex.org/W4317553720, https://openalex.org/W2951449549, https://openalex.org/W4408579100, https://openalex.org/W4289261242, https://openalex.org/W4412932791, https://openalex.org/W2149441684, https://openalex.org/W3217485783, https://openalex.org/W2534390616, https://openalex.org/W4294216483, https://openalex.org/W4321366252, https://openalex.org/W2317662115, https://openalex.org/W2030674117, https://openalex.org/W2578040266, https://openalex.org/W2345356016, https://openalex.org/W3093053585, https://openalex.org/W3107527779, https://openalex.org/W3201829152, https://openalex.org/W2036120890, https://openalex.org/W2145541974, https://openalex.org/W2171707538, https://openalex.org/W1895164037, https://openalex.org/W2612467560, https://openalex.org/W2139132031, https://openalex.org/W3164878156, https://openalex.org/W4304892036, https://openalex.org/W4280630832, https://openalex.org/W2335232153, https://openalex.org/W2124637492, https://openalex.org/W2112868720, https://openalex.org/W3020142913, https://openalex.org/W4388721917, https://openalex.org/W3092428270, https://openalex.org/W4396938299, https://openalex.org/W3094801273, https://openalex.org/W3016044799, https://openalex.org/W4305014652, https://openalex.org/W4313382384, https://openalex.org/W2214074259, https://openalex.org/W4389951851, https://openalex.org/W3196809995, https://openalex.org/W4200307603, https://openalex.org/W4388221408, https://openalex.org/W3192034436, https://openalex.org/W4308766741, https://openalex.org/W2069526613, https://openalex.org/W4399071013, https://openalex.org/W2106947763, https://openalex.org/W4225143246, https://openalex.org/W2086782348, https://openalex.org/W2750588931, https://openalex.org/W2062533676, https://openalex.org/W2147566730, https://openalex.org/W1940319397, https://openalex.org/W2130790725, https://openalex.org/W2112947018, https://openalex.org/W3210558381, https://openalex.org/W2623587811, https://openalex.org/W2410743230, https://openalex.org/W2150318080, https://openalex.org/W4221062827, https://openalex.org/W4323039400, https://openalex.org/W4401854462, https://openalex.org/W3205489811, https://openalex.org/W3036531306, https://openalex.org/W3114785916, https://openalex.org/W2133198677, https://openalex.org/W6893442831, https://openalex.org/W2617425164, https://openalex.org/W4226539308, https://openalex.org/W3103250275, https://openalex.org/W2159482845, https://openalex.org/W3175832391 |
| referenced_works_count | 98 |
| abstract_inverted_index.to | 8 |
| abstract_inverted_index.Our | 0 |
| abstract_inverted_index.and | 16 |
| abstract_inverted_index.from | 13 |
| abstract_inverted_index.their | 17 |
| abstract_inverted_index.counter | 9 |
| abstract_inverted_index.optimal | 4 |
| abstract_inverted_index.protein | 5 |
| abstract_inverted_index.approach | 2 |
| abstract_inverted_index.pathways | 15 |
| abstract_inverted_index.co-target | 6 |
| abstract_inverted_index.discovers | 3 |
| abstract_inverted_index.selecting | 11 |
| abstract_inverted_index.co-targets | 12 |
| abstract_inverted_index.alternative | 14 |
| abstract_inverted_index.connectors. | 18 |
| abstract_inverted_index.resistance, | 10 |
| abstract_inverted_index.combinations | 7 |
| abstract_inverted_index.network-based | 1 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 3 |
| citation_normalized_percentile.value | 0.46763837 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |